Tiny Stem Cell Companies Close In On Major Heart Disease Goals

NEW YORK (Reuters) - The early hope that stem cell therapy would make the paralyzed walk, the blind see and cure diabetes have given way to a long list of failures, highlighted by early stem cell champion Geron Corp abandoning the field in 2011.

Topics:  york reuters     the   geron corp   stem cell   early   
BING NEWS:
  • Entresto puts Novartis at top of docs' ranking of heart disease drug makers, with Pfizer close behind
    In an ongoing battle for dominance in the eyes of healthcare professionals for their work developing heart disease-focused drugs, Novartis has now snatched the top spot from Pfizer, according to a ...
    05/7/2024 - 9:30 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News